Cambridge Antibody - Re Directorate

RNS No 3319f
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
14th July 1997

                            
         Cambridge Antibody Technology Group plc
                            
                   BOARD APPOINTMENTS
 
The  board  of  Cambridge Antibody Technology  Group  plc
("CAT")  is  pleased  to announce two executive  director
appointments.
 
Kevin  Johnson  (BSc, PhD), joins the board  as  Research
Director.    He joined CAT in June 1990 and was appointed
Vice   President  Research  in  January  1995.    He   is
responsible  for  CAT's research  programmes.   Prior  to
joining  CAT  he  was  a  fellow  of  the  University  of
Melbourne,  Australia,  and  John  Lucas  Walker   Senior
Student  at  the University of Cambridge,  where  he  had
previously obtained his PhD.  Kevin Johnson is 36.
 
David  Glover (MA, MB, BChir, MRCP, MFPM) joins the board
as  Medical  Director.  He joined CAT as  Vice  President
Medical  Development  in  November  1994.   He  has  held
previous  posts  as Medical Director of  Schering  Plough
(UK)  and  Director of Medical Affairs with  Merck  &  Co
(UK).   He  has  broad  experience in  drug  development,
regulatory   affairs,  clinical  research   and   medical
marketing  gained  during  his  pharmaceutical   industry
career,  which began in 1984.  Prior to that  he  held  a
series  of  hospital  positions and a  clinical  research
fellowship  at  the  University  of  Birmingham,   having
qualified in medicine from the University of Cambridge in
1976.  David Glover is 44.
 
Professor Peter Garland, Chairman of CAT, said:
 
     "I  am delighted that Kevin Johnson and David Glover
     are  joining  CAT's   board.  They  have  both  made
     highly important contributions to CAT's success  and
     the  board will benefit from their presence.  I  and
     my  colleagues look forward to working with them  in
     the future."
 

 
For further information, please contact:
 
Cambridge  Antibody Technology               01763 263233
David Chiswell, Chief Executive Officer
John Aston, Finance Director
 
Ludgate  Communications                      0171 253 2252
Andrew Nicolls
 
 
END